Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Viking Therapeutics (VKTX) Amortization - Intangibles (2016 - 2018)

Viking Therapeutics' Amortization - Intangibles history spans 5 years, with the latest figure at $146000.0 for Q2 2018.

  • For Q2 2018, Amortization - Intangibles fell 56.68% year-over-year to $146000.0; the TTM value through Mar 2019 reached $146000.0, down 86.85%, while the annual FY2018 figure was $404000.0, 68.51% down from the prior year.
  • Amortization - Intangibles for Q2 2018 was $146000.0 at Viking Therapeutics, down from $258000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $524977.0 in Q2 2016 and bottomed at $6379.0 in Q1 2014.
  • The 5-year median for Amortization - Intangibles is $257000.0 (2017), against an average of $273697.3.
  • The largest annual shift saw Amortization - Intangibles soared 2595.64% in 2015 before it plummeted 56.68% in 2018.
  • A 5-year view of Amortization - Intangibles shows it stood at $294310.0 in 2014, then dropped by 18.28% to $240516.0 in 2015, then soared by 79.29% to $431227.0 in 2016, then tumbled by 39.94% to $259000.0 in 2017, then crashed by 43.63% to $146000.0 in 2018.
  • Per Business Quant, the three most recent readings for VKTX's Amortization - Intangibles are $146000.0 (Q2 2018), $258000.0 (Q1 2018), and $259000.0 (Q4 2017).